21 results
8-K/A
EX-99.2
PYXS
Pyxis Oncology Inc
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
(the “Record Date”) are entitled to vote at the special meeting. The completion of the Pyxis Merger is subject to the satisfaction or waiver of certain … as a tax-free reorganization for U.S. federal income tax purposes. On June 30, 2023, we filed a definitive merger proxy statement announcing a special
424B3
PYXS
Pyxis Oncology Inc
30 Jun 23
Prospectus supplement
4:05pm
Market.
At the special meeting of Apexigen stockholders to be held virtually on August 22, 2023 (the “Apexigen special meeting”), Apexigen stockholders … from time to time of the Apexigen special meeting, if necessary, to solicit additional proxies if there are insufficient shares of Apexigen common
S-4/A
PYXS
Pyxis Oncology Inc
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
completion of the Merger, Apexigen common stock will cease to trade on The Nasdaq Capital Market.
At the special meeting of Apexigen stockholders to be held … virtually on August 22, 2023 (the “Apexigen special meeting”), Apexigen stockholders will be asked to vote on (i) a proposal to adopt the Merger
S-4/A
EX-99.3
PYXS
Pyxis Oncology Inc
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
in the postage-paid envelope provided
You must register to attend the meeting online and/or participate at www.proxydocs.com/APGN
Apexigen, Inc.
Special Meeting … of Stockholders
For Stockholders of record as of June 28, 2023
TIME: August 22, 2023 at 8:00 a.m. Pacific Time
PLACE:
Special Meeting to be held
S-4
EX-99.3
mvup20
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
S-4
tuj2snmoo3s3k536c
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
S-3
nsl1axdjg m669bg
1 Nov 22
Shelf registration
4:51pm
10-K
EX-4.1
b4soh1 dnz3m60ov0ir
29 Mar 22
Annual report
7:36am
10-Q
EX-3.1
o3bws9nt
15 Nov 21
Quarterly report
7:54am
10-Q
EX-3.2
o8guxvcy2u1wggk
15 Nov 21
Quarterly report
7:54am
424B4
fkfswq cd3j
8 Oct 21
Prospectus supplement with pricing info
5:00pm
S-1/A
EX-3.2
x74wor1psklrkwqpnmbg
30 Sep 21
IPO registration (amended)
9:11pm
S-1/A
EX-3.1
is56z3cj trp5
30 Sep 21
IPO registration (amended)
9:11pm
S-1
zc8qkah4yo
17 Sep 21
IPO registration
5:00pm
DRS/A
7vhd521z40i2k9
10 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
13twj2tt fthkw
4 Aug 21
Draft registration statement (amended)
12:00am